Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(852/week)
    • Manufacturing(421/week)
    • Energy(323/week)
    • Technology(827/week)
    • Other Manufacturing(261/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Serotonin

Jan 08, 2020
Are some antidepressants less risky for pregnant women?
Dec 02, 2019
Why Do We Freeze When Startled? New Study in Flies Points to Serotonin
Oct 22, 2019
Altavant Sciences Presents Data at CHEST 2019 Supporting Once-Daily Dosing of Rodatristat Ethyl for the Treatment of Pulmonary Arterial Hypertension
Oct 18, 2019
Altavant Sciences to Present Data Supporting Once-Daily Dosing of Rodatristat Ethyl at CHEST 2019
Oct 01, 2019
Altavant Sciences Presents Data at ERS International Congress 2019 Demonstrating Strong Safety and Tolerability Profile of Rodatristat Ethyl
Jun 26, 2019
HKBU Discovers Mechanisms Underlying Early Life Stress and Irritable Bowel Syndrome
Apr 02, 2019
Motegrity(TM) (prucalopride), the Only Serotonin-4 Receptor Agonist for Adults with Chronic Idiopathic Constipation (CIC), is Now Available in the United States
Mar 13, 2019
Mount Sinai Neuroscience Researchers Discover Surprise Role for Serotonin: The Brain Chemical Can Directly Regulate Gene Expression Inside Brain Cells
Feb 16, 2018
Global Anti-Depressant Drugs Market Expected to Reach $15,983 Million by 2023 - Allied Market Research
Nov 15, 2017
Promius Pharma Announces ZEMBRACE® SymTouch® (Sumatriptan Injection) 3 mg Achieves Primary Endpoint in Post-Approval Clinical Trial
Sep 22, 2017
Allergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) Supplemental New Drug Application (sNDA) for the Treatment of Negative Symptoms in Schizophrenia
Jun 21, 2017
Eisai Announces Lorcaserin HCl CAMELLIA-TIMI 61 Study will Continue as Planned Based on Interim Safety Analysis by Independent Data Monitoring Committee (DMC)

Latest News

Jul 10, 2025

Ionic Mineral Technologies Closes Oversubscribed $29 Million Series B to Scale U.S. Production of Advanced...

Jul 10, 2025

Balboa Geo to Participate in the 2025 ESRI User Conference, San Diego - July 14-18

Jul 10, 2025

E3 Lithium Announces Arrival of Equipment for the Demonstration Facility at the Clearwater Project Site

Jul 10, 2025

QAD | Redzone Supercharges EMEA Expansion with Appointment of Ahmad Salama as General Manager

Jul 10, 2025

IFF Expands Innovation Center in Singapore with New Immersive Experience Hub

Jul 10, 2025

Northrop Grumman Completes Key Test for Exoplanetary Ascent Propulsion

Jul 10, 2025

Protected logistics truck: Rheinmetall MAN Military Vehicles presents new TGS-Mil Protected

Jul 10, 2025

RTX's Raytheon demonstrates autonomous capabilities of its Barracuda mine neutralizer

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia